BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34913855)

  • 21. Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years.
    Bhatt SP; Kim YI; Harrington KF; Hokanson JE; Lutz SM; Cho MH; DeMeo DL; Wells JM; Make BJ; Rennard SI; Washko GR; Foreman MG; Tashkin DP; Wise RA; Dransfield MT; Bailey WC;
    Thorax; 2018 May; 73(5):414-421. PubMed ID: 29326298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Race Adjustment of Pulmonary Function Tests in the Diagnosis and Management of COPD: A Scoping Review.
    Davidson SR; Idris MY; Awad CS; Henriques King M; Westney GE; Ponce M; Rodriguez AD; Lipsey KL; Flenaugh EL; Foreman MG
    Int J Chron Obstruct Pulmon Dis; 2024; 19():969-980. PubMed ID: 38708410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease.
    Schroeder JD; McKenzie AS; Zach JA; Wilson CG; Curran-Everett D; Stinson DS; Newell JD; Lynch DA
    AJR Am J Roentgenol; 2013 Sep; 201(3):W460-70. PubMed ID: 23971478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Impact of Depressive Symptoms and FEV
    O'Toole J; Woo H; Putcha N; Cooper CB; Woodruff P; Kanner RE; Paine R; Bowler RP; Comellas A; Hoth KF; Krishnan JA; Han M; Dransfield M; Iyer AS; Couper D; Peters SP; Criner G; Kim V; Barr RG; Martinez FJ; Hansel NN; Eakin MN;
    Ann Am Thorac Soc; 2022 Feb; 19(2):171-178. PubMed ID: 34410883
    [No Abstract]   [Full Text] [Related]  

  • 25. Influences of Two FEV
    Wei D; Wang Q; Liu S; Tan X; Chen L; Tu R; Liu Q; Jia Y; Liu S
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2053-2065. PubMed ID: 36081764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperpolarized (3)He ventilation defects used to predict pulmonary exacerbations in mild to moderate chronic obstructive pulmonary disease.
    Kirby M; Pike D; Coxson HO; McCormack DG; Parraga G
    Radiology; 2014 Dec; 273(3):887-96. PubMed ID: 24960283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computed Tomography-based Airway Surface Area-to-Volume Ratio for Phenotyping Airway Remodeling in Chronic Obstructive Pulmonary Disease.
    Bodduluri S; Kizhakke Puliyakote A; Nakhmani A; Charbonnier JP; Reinhardt JM; Bhatt SP
    Am J Respir Crit Care Med; 2021 Jan; 203(2):185-191. PubMed ID: 32755486
    [No Abstract]   [Full Text] [Related]  

  • 28. Diffusing Capacity of Carbon Monoxide in Assessment of COPD.
    Balasubramanian A; MacIntyre NR; Henderson RJ; Jensen RL; Kinney G; Stringer WW; Hersh CP; Bowler RP; Casaburi R; Han MK; Porszasz J; Barr RG; Make BJ; Wise RA; McCormack MC
    Chest; 2019 Dec; 156(6):1111-1119. PubMed ID: 31352035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Method for Combined Quantitative Assessment of Air-Trapping and Emphysema on Chest Computed Tomography in Chronic Obstructive Pulmonary Disease: Comparison with Parametric Response Mapping.
    Hwang HJ; Seo JB; Lee SM; Kim N; Yi J; Lee JS; Lee SW; Oh YM; Lee SD
    Korean J Radiol; 2021 Oct; 22(10):1719-1729. PubMed ID: 34269529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of FEV
    Yee N; Markovic D; Buhr RG; Fortis S; Arjomandi M; Couper D; Anderson WH; Paine R; Woodruff PG; Han MK; Martinez FJ; Barr RG; Wells JM; Ortega VE; Hoffman EA; Kim V; Drummond MB; Bowler RP; Curtis JL; Cooper CB; Tashkin DP; Barjaktarevic IZ
    Chest; 2022 Apr; 161(4):949-959. PubMed ID: 34767825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benefits of Tiotropium/Olodaterol Compared with Tiotropium in Patients with COPD Receiving only LAMA at Baseline: Pooled Analysis of the TONADO
    Buhl R; Singh D; de la Hoz A; Xue W; Ferguson GT
    Adv Ther; 2020 Aug; 37(8):3485-3499. PubMed ID: 32462607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of the desaturation-distance ratio from the six-minute walk test for patients with COPD.
    Fujimoto Y; Oki Y; Kaneko M; Sakai H; Misu S; Yamaguchi T; Mitani Y; Yasuda H; Ishikawa A
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2669-2675. PubMed ID: 28919734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of CT quantified emphysema, air trapping and airway wall thickness on pulmonary function in male smokers with and without COPD.
    Mohamed Hoesein FA; de Jong PA; Lammers JW; Mali WP; Mets OM; Schmidt M; de Koning HJ; Aalst Cv; Oudkerk M; Vliegenthart R; Ginneken Bv; van Rikxoort EM; Zanen P
    COPD; 2014 Sep; 11(5):503-9. PubMed ID: 25093696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
    Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Native American ancestry, lung function, and COPD in Costa Ricans.
    Chen W; Brehm JM; Boutaoui N; Soto-Quiros M; Avila L; Celli BR; Bruse S; Tesfaigzi Y; Celedón JC
    Chest; 2014 Apr; 145(4):704-710. PubMed ID: 24306962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix metalloproteinase-9 predicts pulmonary status declines in α1-antitrypsin deficiency.
    Omachi TA; Eisner MD; Rames A; Markovtsova L; Blanc PD
    Respir Res; 2011 Mar; 12(1):35. PubMed ID: 21429222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Values of Body Mass Index and Chest CT Features in the Assessment of Chronic Obstructive Pulmonary Disease].
    Li L; Liu Y; Li J; Gao JM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Feb; 42(1):55-61. PubMed ID: 32131940
    [No Abstract]   [Full Text] [Related]  

  • 39. Childhood pneumonia increases risk for chronic obstructive pulmonary disease: the COPDGene study.
    Hayden LP; Hobbs BD; Cohen RT; Wise RA; Checkley W; Crapo JD; Hersh CP;
    Respir Res; 2015 Sep; 16(1):115. PubMed ID: 26392057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET.
    Kellerer C; Jörres RA; Schneider A; Alter P; Kauczor HU; Jobst B; Biederer J; Bals R; Watz H; Behr J; Kauffmann-Guerrero D; Lutter J; Hapfelmeier A; Magnussen H; Trudzinski FC; Welte T; Vogelmeier CF; Kahnert K
    Respir Res; 2021 Sep; 22(1):242. PubMed ID: 34503520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.